RBC Capital analyst Arun Viswanathan upgraded Chemours to Outperform from Sector Perform with a price target of $40, up from $28.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on CC:
- DuPont, Chemours, Corteva reach settlement agreement with state of Ohio
- Chemours, DuPont and Corteva reach settlement agreement with Ohio for $110M
- Appeals court tosses lawsuit against ‘forever chemical’ companies, Axios says
- Chemours expanding production of Chemours HFC-152a by about 20%
- Chemours price target lowered to $28 from $30 at RBC Capital